Drug Type Small molecule drug |
Synonyms GH 31, GH-31 |
Target |
Action inhibitors |
Mechanism Mat2A inhibitors(S-adenosylmethionine synthase isoform type-2 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | IND Approval | China | 05 Jan 2026 | |
| Methylthioadenosine phosphorylase deletion cancer | IND Approval | United States | 04 Jan 2026 | |
| Methylthioadenosine phosphorylase deletion cancer | IND Approval | China | 04 Jan 2026 |





